AXAxinet
Menu
Finance

Live market screen

Commercial Space Company Risk / Opportunity Ranking

Opportunity/risk view across launch, satellites, SAR, earth observation, defense demand, financing events, and execution risk.

Updated June 27, 2026

Companies analyzed
438
Ranked rows
876
Evidence links
356
Rows per page
20

Opportunity view

Showing rows 121-140 of 438; 20 rows per page.

Sorted by raw opportunity score
RankCompanyScoreThesis / Evidence
121
Azista Industries Private Limited
lowweak
Opp 3
Risk 2

Thesis: Reviewed evidence rationale says Azista Industries successfully imaged the ISS using its AFR satellite and notes potential uses in space situational awareness and missile monitoring. If current, successful imaging and dual-use application potential support a modest 1 year+ opportunity case.

Why now: The only support cited is article in the membership rationale. Because the company coverage report shows zero articles after recent evidence window and zero evidence after recent evidence window, there is no robust timing catalyst beyond the historical demonstration narrative.

Caveats: Single-article support only, and not available as active evidence. No direct evidence on customer conversion, regulatory adoption, or funding. Private-company visibility is limited in these reviewed sources.

122
Bellatrix Aerospace
lowweak
Opp 3
Risk 2

Thesis: Reviewed evidence membership rationale describes Bellatrix Aerospace as a space propulsion company partnering on a VLEO satellite mission using its air-breathing electric propulsion platform. If current, that points to differentiated technology and a potentially durable 1-year-plus opportunity setup, but the reviewed sources lack citeable direct evidence or article.

Why now: Why now is only moderate in theory because propulsion/platform partnerships can matter over a 1-year-plus horizon, but these reviewed sources does not provide recency-anchored evidence after recent evidence window.

Caveats: No direct evidence with available for citation. Technology differentiation is only inferred from membership rationale and is not independently corroborated in available evidence.

123
D-Orbit
lowweak
Opp 3
Risk 2

Thesis: D-Orbit appears strategically positioned in space logistics and in-orbit servicing, with reviewed sources rationale referencing an ESA award and supporting context noting prior Series D funding, but the retained in-window evidence is weak and mostly undated context.

Why now: Why-now is weak because retained evidence after recent evidence window is mostly undated context; one cited article is from February 14, 2026 and therefore outside the 90-day evidence window, while the remaining available context is undated.

Evidence
  • Undated context: lists D-Orbit as operating in in-orbit servicing and assembly. spaceindex.io

Caveats: Reviewed evidence membership rationale mentions a €119 million ESA contract, but no citeable retained row for that contract is included here. Series D funding mention is in a February 14, 2026 article outside the 90-day recent evidence window. Undated context is not recency proof.

124
Fujitsu
lowweak
Opp 3
Risk 1

Thesis: Fujitsu has a plausible long-horizon opportunity angle because the reviewed sources' membership rationale says it signed an MOU with BULL to develop a high-precision space situational awareness service for Japan. That suggests direct participation in an SDA-related service, but the reviewed sources still frames Fujitsu primarily as a large IT/services company and provides no direct positive evidence row or after recent evidence window (: and; not provided in reviewed sources).

Why now: An MOU in SDA could matter over a 1 year+ horizon if it converts into deployments or service revenue, but the reviewed sources offers no direct dated evidence inside recent evidence window and no article to validate timing.

Caveats: Large diversified company; reviewed sources does not show materiality of space effort. MOU is weaker than signed commercial contract revenue evidence. No direct article content or is available in reviewed sources.

125
GalaxySpace
lowweak
Opp 3
Risk 2

Thesis: GalaxySpace has some strategic optionality because the reviewed sources say it set up a space computing research institute and places it in space computing and satellite communications context, but that is early and not enough for a strong opportunity call.

Why now: The reviewed sources references article: for the research institute setup, yet does not provide the article or direct event details to assess timing or commercial conversion.

Caveats: Only one article is considered and no representative article object is provided. Research institute formation is weaker than product, contract, or financing milestones. Commercial impact timing is unclear.

126
Gate Space
lowweak
Opp 3
Risk 2

Thesis: Gate Space has a modest opportunity case because an undated supporting article context item says it won 6.3 million euros in funding from a government-backed accelerator program, which could support longer-horizon development if still current

Why now: For a 1 year+ horizon, funding can matter, but recency is uncertain because the article is explicitly undated and the reviewed sources say undated external evidence is relevance context rather than recency proof

Evidence
  • Representative article summary says Gate Space is an Austrian satellite propulsion startup that has won 6.3 million euros ($7.2 million) in funding from Europe's government-backed accelerator program. spacenews.com

Caveats: The evidence is weak context and supporting article context, not direct structured company event/fact evidence. The article is undated; the reviewed sources explicitly says recency-sensitive claims should be treated cautiously. Same-article repeated rows are not independent confirmation.

127
Globalstar
lowweak
Opp 3
Risk 4

Thesis: Globalstar's cohort fit as a satellite communications and direct-to-device company is clear from the membership rationale, but these reviewed sources provide no in-window direct evidence to support a stronger opportunity ranking.

Why now: There is effectively no why-now evidence in this row: the recent evidence review shows zero kept rows after the March 29, 2026 cutoff and no representative articles are provided.

Caveats: The phase-2 rationale mentions Amazon acquisition-related articles, but those supporting articles are not included in the available evidence for this row. Scores remain low because absence of evidence is not positive evidence.

128
Goonhilly Earth Station Ltd
lowweak
Opp 3
Risk 3

Thesis: Among this screen, Goonhilly has the strongest stated strategic relevance because the reviewed sources' membership rationale says it has ground-station/COMSAT revenue and is involved in a transaction with Intuitive Machines, implying potentially durable space-infrastructure relevance over a 1 year+ horizon. However, the reviewed sources provide no retained direct evidence or article summaries to verify timing or terms, so the opportunity case remains weak.

Why now: The only 'why now' available is the reviewed sources' statement that Goonhilly is being acquired by Intuitive Machines, cited in phase-2 support, and: but no, timestamps, or retained evidence are provided, so recency and sequence cannot be validated.

Caveats: The reviewed sources rationale states Goonhilly has ground-station/COMSAT revenue and is being acquired by Intuitive Machines, tied to, and: but no or retained evidence are present. Coverage debug still shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. Because chronology cannot be verified, transaction-state claims should be treated cautiously.

129
GS Yuasa Corporation
lowweak
Opp 3
Risk 1

Thesis: GS Yuasa has the cleanest stated product adjacency in the reviewed sources because the membership rationale says it is listed as a key player in a space battery market report. If that positioning reflects real participation in spacecraft power systems, it could matter over a 1 year+ horizon; however, the reviewed sources provide no retained direct evidence or dated summaries, so the opportunity score remains modest.

Why now: There is no verified near-term catalyst, but the reviewed sources' phase-2 rationale references saying GS Yuasa was named as a key player in a space battery market report. Without, timing detail, or retained evidence, recency is uncertain.

Caveats: The rationale cites, but no or retained article text is provided. Being listed as a key player in a market report is weaker than direct contract, launch, or financial evidence. No retained evidence remain after the 90-day recent evidence window.

130
HEO
lowweak
Opp 3
Risk 2

Thesis: Possible long-horizon opportunity from being listed as operating and from an undated mention of a seven-figure BlackSky space domain awareness expansion contract for automated non-Earth imaging missions, but this is only supporting article context and recency is uncertain.

Why now: Why now is weak because both cited items are undated, so the reviewed sources does not establish a fresh catalyst within the current evidence window. The only support is that HEO appears in current reviewed sources context as an operating company and as associated with a contract mention, but recency cannot be confirmed from the reviewed sources

Evidence
  • Space Index lists HEO in 'In-Orbit Servicing & Assembly Companies' with status 'operating'; article is undated. spaceindex.io
  • Undated article summary says: 'BlackSky Signs Seven-Figure Space Domain Awareness Expansion Contract with HEO for Fully Automated Non-Earth Imaging Missions.' talksatellite.com

Caveats: Both supporting items are undated, so recency is uncertain. Support is supporting article context, not stronger company-specific dated event evidence. Same-article repeated rows in the reviewed sources are not independent confirmation.

131
Hula Earth
lowweak
Opp 3
Risk 1

Thesis: There is a weak, article-level opportunity case that Hula Earth is an early-stage biodiversity monitoring platform using satellite imagery and that it had raised seed funding by the time of the cited profile, which could support long-horizon company development. However, this is not direct event/fact evidence in the reviewed sources; it is external article context only.

Why now: The only dated retained context is a Startup Intros profile with April 16, 2026, stating Hula Earth uses IoT sensors and satellite imagery and had raised €1.6 million in seed funding; that is recent enough for a 1 year+ watchlist but too weak for a high-conviction thesis.

Evidence
  • Hula Earth develops an automated platform utilizing IoT BioT sensors and satellite imagery to monitor biodiversity in real time and 'raised €1.6 million in seed funding in November 2024'; April 16, 2026. startupintros.com

Caveats: Evidence is weak context and supporting article context, not direct company event/facts. The funding itself is described as having occurred in November 2024 inside an April 16, 2026 profile, so exact recency of the financing event is older than the profile date. Reviewed evidence itself says Earth observation fit is plausible but not strong from these reviewed sources alone.

132
HyPrSpace
lowweak
Opp 3
Risk 4

Thesis: HyPrSpace has some long-horizon upside as a launch startup because the reviewed sources membership rationale says it raised a €21M Series A and is developing hybrid propulsion for a small launch vehicle and suborbital prototype.

Why now: The reviewed sources does not provide recent evidence window-supported article details for the cited raise and development milestones, so the timing case is under-evidenced.

Caveats: No representative articles or direct evidence are available after recent evidence filtering. The opportunity view rests only on the membership rationale rather than article-level evidence available for citation.

133
Institute for Q-shu Pioneers of Space, Inc (iQPS)
lowweak
Opp 3
Risk 2

Thesis: The reviewed sources say iQPS is a private Japanese Earth-imaging company whose QPS-SAR satellites are launched on Rocket Lab missions. That indicates a functioning path to deployment and a potentially scalable SAR imaging platform over a 1 year+ horizon.

Why now: Why now is only modest because launch-linked deployment could matter over a long horizon, but there are no available article summaries or dated events to establish current momentum.

Caveats: Membership rationale references article IDs and, but no or summaries are provided. No direct evidence survived or were available into these reviewed sources after recent evidence window. Do not use relation context as counterparty propagation evidence.

134
IonQ
lowweak
Opp 3
Risk 3

Thesis: IonQ has a possible strategic long-horizon opportunity if the reviewed sources' referenced Capella Space subsidiary linkage and SDA prototype agreement ultimately create material space exposure, but the reviewed sources does not allow straightforward propagation from subsidiary or relation context to IonQ itself without stronger direct evidence.

Why now: Potential 'why now' would be the referenced space-subsidiary contract pathway, but recency and direct materiality to IonQ are not validated in available evidence for the 90-day recent evidence window.

Caveats: Phase-2 rationale references and: but no or summaries are provided in the reviewed sources. Relations and counterparty propagation are not allowed by default. Coverage debug shows zero evidence after recent evidence window despite a large article universe.

135
ispace
lowweak
Opp 3
Risk 4

Thesis: The reviewed sources places ispace in private lunar mission context and notes 'ispace Hakuto-R,' which indicates continuing relevance in lunar mission execution if the program remains active.

Why now: The membership support cites: and: The reviewed sources' wording around a second attempt makes mission outcome and execution durability relevant over a 1 year+ horizon, but timing confidence is reduced because no evidence survived into the available set.

Caveats: Risk thesis is inferred from reviewed sources rationale mentioning a prior failure, not from available direct negative evidence. No direct evidence confirms current mission status, financing, or customer pipeline. Recency and sequencing of mission milestones cannot be validated from the empty evidence table.

136
Kepler Aerospace
lowweak
Opp 3
Risk 3

Thesis: Reviewed evidence context describes Kepler Aerospace as an Indian New Space startup operating a GSaaS network, integrating ground stations, and working on CubeSat platforms and satellite communications infrastructure. That breadth could support a 1 year+ infrastructure thesis, but there is no available in-window evidence of contracts, deployments, or financing progress.

Why now: No current catalyst is established. Membership support references article ID: but the reviewed sources provide no and shows no evidence after recent evidence window.

Caveats: No direct evidence available after recent evidence window for this company. Membership rationale references article ID: but the reviewed sources provide no or article summary. Context includes relation/fact counts in support statistics, but relations are context-only and cannot be propagated as operating proof.

137
Kepler Communications
lowweak
Opp 3
Risk 2

Thesis: The reviewed sources places Kepler Communications in space communications, HydRON network or optical communications context, and also notes it as an Nvidia space-AI customer. If accurate and current, those references could support a strategic network and onboard compute opportunity over 1 year+.

Why now: The reviewed sources references, and: in membership support, suggesting recent strategic context, but no post-recent evidence window evidence are actually available for scoring.

Caveats: Reviewed evidence itself says support is somewhat contextual. Context-only references are weaker than direct event/fact evidence. No available evidence confirms deployment, revenue, or funding milestones.

138
LiveEO
lowweak
Opp 3
Risk 2

Thesis: Reviewed evidence rationale says LiveEO secured ESA funding for the Twinspector satellite constellation for infrastructure monitoring, which could support a 1 year+ commercialization path, but there is no directly citable within the recent evidence window evidence in the reviewed sources.

Why now: Why-now cannot be established because no evidence remain after recent evidence filtering.

Caveats: Phase2 membership rationale references, but no summary or evidence are provided for citation. Coverage debug shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. Low scores reflect missing usable evidence, not a bearish business judgment.

139
Mach Industries
lowweak
Opp 3
Risk 2

Thesis: Among this screen, Mach Industries has one of the stronger but still weakly grounded setups because the reviewed sources' membership rationale says it is a startup that raised $300 million and builds aerospace/defense systems including a 'Stratos satellite platform.' If accurate, that suggests longer-horizon capital availability and product ambition, but the reviewed sources provide no direct positive evidence row or after recent evidence window to validate scale, timing, or execution (: not provided in reviewed sources).

Why now: For a 1 year+ horizon, a large raise and mention of a satellite platform could matter if recent, but the reviewed sources does not provide usable dated evidence within the 90-day recent evidence window and explicitly reports zero available evidence after recent evidence window.

Caveats: No article provided in reviewed sources. No direct event/facts are available after recent evidence window despite the membership rationale referencing a raise. Primarily defense-tech framing may limit pure-play space thesis relevance.

140
Maxar Technologies Inc.
lowweak
Opp 3
Risk 2

Thesis: Maxar has some residual opportunity appeal because the membership rationale cites a specific $500 million NASA deal in a commercial satellite imaging market report, which would be material if current, but the reviewed sources includes no retained evidence row or recent article summary to validate status or timing now.

Why now: No retained evidence is available within the reviewed sources despite the membership rationale referencing a prior NASA deal article. That makes the name a weak current candidate under local-evidence-only rules.

Caveats: No retained article summary or dated event row is provided for the cited NASA deal. Cannot elevate conviction based only on membership rationale.

Risk view

Showing rows 61-80 of 438; 20 rows per page.

Sorted by raw risk score
RankCompanyScoreThesis / Evidence
61
Xoople
mediummedium
Opp 6
Risk 4

Thesis: Article-level context also highlights structural Earth observation monetization difficulty and long procurement cycles, creating real commercialization risk even after the raise.

Why now: Xoople closed a $130 million Series B on April 6, 2026/07 and articles say the capital is for building out its constellation; for a 1 year+ horizon, that financing can enable product and deployment progress, but the same dated coverage warns the market has historically been hard to monetize.

Evidence
  • Published April 7, 2026: article says Earth observation data is easy to promote but difficult to turn into profit, with long procurement processes and commercial market under-realization. techfundingnews.com
  • Published April 6, 2026: Xoople closed a $130 million Series B and is developing a satellite constellation to collect data aimed at deep learning models. techcrunch.com
  • Published April 6, 2026: Xoople closed a $130 million Series B for AI Earth mapping. techbuzz.ai

Caveats: Positive support is mostly supporting article context rather than positive evidence. Commercialization warning is article context, not a company-specific deterioration event. No direct customer, backlog, or launch milestone evidence is available.

62
AAC Clyde Space AB
lowweak
Opp 3
Risk 3

Thesis: There is no direct adverse evidence in the reviewed sources, so risk is moderate-low and mostly reflects inability to verify current contract progression, funding conversion, or execution status from available evidence (: unavailable in reviewed sources).

Why now: Why now is weak because the reviewed sources' recent evidence review and coverage data show zero available evidence after recent evidence window despite the membership rationale referencing a material contract.

Caveats: No current evidence is provided for Contract claim appears only in membership rationale, not in available direct evidence fields. No recency-confirmed follow-through evidence is available.

63
Aavuus
mediummedium
Opp 5
Risk 3

Thesis: Aavuus remains early-stage, and the evidence is supporting article context rather than direct positive events; the same article describes only pre-seed funding, which implies execution and scaling risk over a 1 year+ horizon.

Why now: The opportunity is timely because the retained article is dated June 9, 2026 and describes a current financing and product build phase rather than stale background context. That said, recency comes from source date/article date, and evidence grounding is still article-level rather than direct fact/events., June 9, 2026

Evidence
  • Aavuus has raised pre-seed funding from Maki.vc and is developing a global laser-based tracking network to improve collision avoidance and close a critical visibility gap in Low Earth Orbit. tech.eu

Caveats: Evidence is weak context and supporting article context, not direct structured positive event evidence. No explicit customer, contract, revenue, or regulatory milestone is cited. Same article appears in multiple rows and is not independent confirmation.

64
Applied Atomics
lowweak
Opp 2
Risk 3

Thesis: Risk is modestly elevated because the reviewed sources' membership rationale describes it as a startup that emerged from stealth and raised only a $4M pre-seed, implying early-stage execution and financing risk, but this is not backed by available dated evidence in the ranking payload.

Why now: There is no available dated evidence in the reviewed sources after recent evidence filtering, so recency-based ranking support is weak.

Caveats: No representative articles or evidence are available after recent evidence filtering for ranking support. The phase2 membership rationale mentions a $4M pre-seed and Star Reacher Network, but the cited supporting articles are not provided with usable article summaries or evidence in these reviewed sources.

65
Astrolab
lowweak
Opp 3
Risk 3

Thesis: No direct negative evidence is available; the main risk in this ranking is evidence insufficiency rather than a documented adverse development.

Why now: Why-now support is weak because coverage data shows no evidence after recent evidence window, so the cited lunar contract context cannot be refreshed from available evidence.

Caveats: Phase2 rationale cites, and: but no representative article or evidence are available for direct citation. Coverage data reports articles after recent evidence window = 0 and evidence after recent evidence window = 0. Private-company watch item rather than high-conviction ranked candidate.

66
Astroscale
lowweak
Opp 5
Risk 3

Thesis: No direct negative evidence is available. Remaining risk comes from the lack of post-recent evidence window evidence proving contract conversion, revenue realization, or mission execution scale.

Why now: Why now is relatively constructive because a named partnership for on-orbit services can matter over a long strategic horizon, but exact timing and materiality cannot be validated from the reviewed sources because only membership rationale is visible.

Caveats: Membership rationale references article ID: but the reviewed sources provide no or article summary. Relation counts are present in support metadata, but relations are context-only unless separately policy-gated. No direct positive or negative evidence arrays are populated.

67
Axelspace Corporation
lowweak
Opp 3
Risk 3

Thesis: No material negative evidence is present; risk is mainly execution and evidence-gap risk because current launch timing, deployment success, and monetization are not substantiated by the available reviewed sources evidence (: unavailable in reviewed sources).

Why now: Why now is weak because the reviewed sources references a potentially important constellation expansion but provides no post-recent evidence window available evidence to confirm status or timing.

Caveats: No current evidence is provided for No direct evidence remained after the recent evidence filter. Recency of constellation expansion cannot be validated from reviewed sources fields.

68
CAS Space
lowweak
Opp 2
Risk 3

Thesis: Risk is modestly elevated because the membership rationale describes IPO and reusable rocket development ambitions, both of which imply capital intensity and execution risk, but there is no available adverse evidence.

Why now: There is no usable dated evidence available after recent evidence filtering, so the reviewed sources does not provide a clear timing catalyst.

Caveats: The membership rationale references an IPO and Lijian-1 launch activity, but those source articles are not included with ranking-usable details in these reviewed sources.

69
CesiumAstro
lowweak
Opp 5
Risk 3

Thesis: The positive financing evidence is stale relative to the reviewed sources' 90-day recent evidence window. The article is dated February 14, 2026, which the reviewed sources say was dropped by the recent evidence filter, so there is no current-window evidence confirming whether financing momentum, backlog conversion, or product adoption continued

Why now: There is no fresh catalyst inside the 90-day evidence window. The visible article was published on February 14, 2026 and is outside the cutoff date of March 29, 2026, so it is useful as background but weak for recency-sensitive ranking

Evidence
  • February 14, 2026: 'CesiumAstro (US) raised a $270M Series C round (total funding: $655M). The company provides out-of-the-box communication systems for satellites, UAVs, launch vehicles, and other space or airborne platforms.' spaceambition.substack.com

Caveats: The visible positive article is outside the 90-day recent evidence window cutoff and was dropped from reviewed evidence. External supporting source context is allowed as evidence context but is not merged into primary data source.

70
ClearSpace
mediummedium
Opp 7
Risk 3

Thesis: Risks center on execution and evidence quality rather than explicit adverse news. The financing article carries internal chronology ambiguity because the page was published in 2026 but references a January 19, 2023 financing round, and the overall reviewed sources lack direct negative events, contract-performance data, or milestone completion proof.

Why now: Why now is supported by recent dated context: on June 24, 2026, SpaceNews reported ClearSpace signed an MOU with Shield Space to develop sovereign space defense capabilities for the UK and allies, indicating adjacent market expansion. On May 19, 2026, the company site said it had finalized a EUR 26.7 million Series A and was ramping operations ahead of ClearSpace-1 scheduled to launch in 2026. These dated items fit a 1 year+ horizon because they point to ongoing commercialization and mission preparation.

Evidence
  • Published June 24, 2026, SpaceNews said Shield Space and ClearSpace signed an MOU on June 23 to develop sovereign space defense capabilities for the UK and allies using ClearSpace's in-orbit servicing capabilities. spacenews.com
  • Published May 19, 2026, ClearSpace said it finalized a EUR 26.7 million Series A and was ramping operations ahead of ClearSpace-1, scheduled to launch in 2026. clearspace.today
  • Published May 19, 2026, the company timeline states ESA designated ClearSpace to lead the first mission to remove debris from orbit by 2028 and lists collaborations, certification, and prior mission selections. clearspace.today

Caveats: Most evidence is supporting article context, not direct positive events. The financing article published on May 19, 2026 references January 19, 2023 for the Series A round, so funding recency versus page recency should not be conflated.

71
D-Orbit
lowweak
Opp 4
Risk 3

Thesis: No direct negative evidence is present. Risk remains moderate because the evidence base is only one cited article with no available direct events, leaving uncertainty on commercialization, timeline, and conversion from demonstration activity to durable revenue.

Why now: Why now is the partnership/demo claim referenced in article ID, but the reviewed sources includes neither nor explicit article timing beyond the article ID prefix, limiting recency precision.

Caveats: Opportunity rests on membership rationale rather than fully available direct evidence. Referenced article ID has no in the reviewed sources. Demo activity is not the same as proven commercial traction.

72
Dawn Aerospace
mediummedium
Opp 7
Risk 3

Thesis: Risk is non-trivial because the thesis depends on execution of a global rollout in a capital-intensive reusable space transportation market, but the reviewed sources does not show direct adverse events. Risk is therefore moderate rather than high.

Why now: The key catalyst is recent and explicit: on June 16, 2026 the company announced the Series B close and said the proceeds will finance global rollout and scaling of commercial and operational teams in the US and Europe.

Evidence
  • June 16, 2026. Summary says Dawn Aerospace closed a $25 million Series B at a $195 million post-money valuation to accelerate global expansion of reusable space transportation. dawnaerospace.com
  • The company states the Series B will directly finance global rollout, scaling commercial and operational teams in the US and Europe to support its expanding international customer base. dawnaerospace.com

Caveats: Evidence comes from a company-published article, so it is not fully independent. No direct structured positive event row is provided beyond supporting article context.

73
Earth Eye Co
lowweak
Opp 2
Risk 3

Thesis: Because the reviewed sources frames the company around surveillance/spy satellite activity rather than commercial traction, and provides no direct positive operating evidence, the name screens as a limited-visibility watchlist with modest evidence-based risk.

Why now: Why now is weak because there are no available post-recent evidence window evidence, no article summaries, and no clear near- or long-horizon catalyst beyond generic association with a surveillance satellite.

Caveats: Membership rationale cites article IDs and, but the reviewed sources provide no. Company is private and evidence coverage inside the recent evidence window is empty.

74
EDGX
lowweak
Opp 4
Risk 3

Thesis: Execution and financing risk remain material because the reviewed sources contain no kept direct evidence on follow-on funding, customer adoption, revenue conversion, or post-demo performance; technology demonstration does not by itself prove scale-up.

Why now: The membership support references articles, and, implying a narrative of funding plus orbital demonstration, but active evidence remains empty after recent evidence filtering, limiting recency confidence.

Caveats: In-orbit demo claim appears only in reviewed sources rationale, not available direct evidence. No evidence confirms whether the prior seed round falls within the current decision horizon relevance. No direct adverse evidence is present, but that is not proof of low fundamental risk.

75
Ellipsis Drive
lowweak
Opp 4
Risk 3

Thesis: Risk is mostly commercialization uncertainty. The reviewed sources does not provide direct negative evidence, but it also lacks direct available proof of revenue, customer conversion, or broader market adoption.

Why now: Why now is the reviewed sources' claim that the company addresses a key EO data-processing bottleneck and has space-agency support, referenced to article ID: though no or timestamp detail was provided.

Caveats: Claims come from membership rationale rather than direct evidence. Referenced article ID: lacks a reviewed sources. Support from agencies and target users is weaker than demonstrated contracted revenue.

76
EON Space Labs
lowweak
Opp 1
Risk 3

Thesis: The reviewed sources' clearest adverse context is that EON Space Labs was identified as one of the Indian private space companies affected by a PSLV failure, which could create execution, schedule, or financing ripple effects over a 1 year+ horizon, though the underlying article detail is not surfaced in the scoring evidence fields.

Why now: Why now is stronger than for most names here because the phase2 rationale specifically ties EON Space Labs to a PSLV failure context via article: implying a concrete event rather than generic company context. However, conviction remains low because the reviewed sources omits the underlying event summary and dates in the evidence exposed here.

Caveats: The adverse signal appears only in phase2 rationale, not in direct negative evidence. No article summary, quote, or timing detail is provided in the scoring fields. Impact magnitude on EON specifically cannot be quantified from these reviewed sources alone.

77
Eycore
mediumweak
Opp 5
Risk 3

Thesis: Risk remains moderate because the reviewed sources offers only one supporting article context and no direct positive event row beyond that summary, leaving unclear whether the satellite is generating revenue, delivering performance, or leading to follow-on orders.

Why now: Why now is the dated first-satellite launch article from May 5, 2026, which is recent within the 90-day recent evidence window and relevant to a long-horizon de-risking story, though still early-stage.

Evidence
  • SpaceNews summary says Eycore launched Eycore-1, an Earth observation satellite equipped with the company's synthetic aperture radar technology. Article timestamp May 5, 2026. spacenews.com

Caveats: Evidence is supporting article context only, not a stronger structured positive event row. Single-article universe limits corroboration. No financing, customer, revenue, or performance follow-through evidence is provided.

78
GITAI
mediummedium
Opp 6
Risk 3

Thesis: Execution and commercialization risk remain meaningful because the retained evidence is still mainly company-provided article context and a technology demonstration milestone, not third-party validated contract wins, revenue conversion, or mission success; an undated directory listing that GITAI is 'operating' is weaker context and not recency proof.

Why now: The key catalyst is recent and inside recent evidence window: on June 16, 2026, GITAI announced completion of the S3 flight model for an on-orbit servicing demonstration mission, which is directly relevant to a 1 year+ horizon because it may precede launch, demonstration, and downstream defense/commercial adoption over the next year.

Evidence
  • GITAI announced completion of the flight model of its S3 robotic satellite mission, a technology demonstration mission designed to validate advanced on-orbit servicing technologies. gitai.tech
  • The mission is described as demonstrating the company's modular spacecraft architecture supporting future defense-focused low Earth orbit constellation services. gitai.tech

Caveats: Primary evidence is from the company itself. No retained independent customer, contract, or revenue evidence is provided. The spaceindex.io entry is undated and should not be treated as recency proof.

79
Goonhilly Earth Station Ltd
lowweak
Opp 3
Risk 3

Thesis: The same reviewed sources rationale says Goonhilly is being acquired by Intuitive Machines, which can create integration, ownership, and business-state uncertainty over a 1 year+ horizon. Because no retained dated evidence are available, this risk is only moderately ranked.

Why now: The only 'why now' available is the reviewed sources' statement that Goonhilly is being acquired by Intuitive Machines, cited in phase-2 support, and: but no, timestamps, or retained evidence are provided, so recency and sequence cannot be validated.

Caveats: The reviewed sources rationale states Goonhilly has ground-station/COMSAT revenue and is being acquired by Intuitive Machines, tied to, and: but no or retained evidence are present. Coverage debug still shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. Because chronology cannot be verified, transaction-state claims should be treated cautiously.

80
ICEYE
highstrong
Opp 9
Risk 3

Thesis: The reviewed sources does not show material adverse company-specific events; main risk is that most support is financing/context evidence rather than audited operating metrics or margins.

Why now: On June 9, 2026 ICEYE disclosed a €450 million primary Series F at valuation above €10 billion, with total round size above €1 billion including secondary, and later June context also referenced a €300 million revolving credit facility and additional sovereign satellite demand; those are recent business-state signals for a 1 year+ horizon.

Evidence
  • Published June 9, 2026: ICEYE raised EUR 450 million in a primary Series F led by General Atlantic at a valuation of over EUR 10 billion; total funding round exceeded EUR 1 billion including secondary. iceye.com
  • Published June 9, 2026: Iceye raised more than 1 billion euros to expand SAR satellite systems. spacenews.com
  • Published June 15, 2026: article says ICEYE raised €450 million primary capital at >€10 billion valuation, total round above €1 billion, and had originated a €300 million three-year revolving credit facility on May 22, 2026. beinsure.com

Caveats: Some support is supporting article context rather than company-specific positive evidence. Several supporting demand/customer references are undated, so recency is uncertain for those claims.